Key result
Intrathecal substance P antagonists or antiserum attenuated MAP and heart rate responses to PPr stimulation but augmented MAP responses to rVLM stimulation in anesthetized cats.
Why the study?
Does intrathecal substance P antagonism alter mean arterial blood pressure and heart rate responses in chloralose-anesthetized cats undergoing rVLM and PPr stimulation?
Does intrathecal substance P antagonism alter mean arterial blood pressure and heart rate responses in chloralose-anesthetized cats undergoing rVLM and PPr stimulation?
Substance P can either increase or decrease the mean arterial pressure response depending on whether the parapyramidal region or rostral ventrolateral medulla pathway is activated.
Site-specific substance P effects on feline pressor responses are hypothesis-generating; translational studies needed before any clinical consideration.
Rostral ventrolateral medulla (rVLM) and parapyramidal region (PPr) serve as important medullary control sites for sympathoexcitation. rVLM and PPr have direct projections to the intermediolateral cell column (IML) that are thought to be important in maintaining mean arterial blood pressure (MAP). Substance P (SP) is found in PPr neurons and in and near the subretrofacial area of the rVLM. At least some of these cells project to the IML. We investigated the involvement of SP at the IML in mediating rVLM- and PPr-evoked pressor responses in the chloralose-anesthetized cat. Pressor responses to electrical and chemical PPr and rVLM stimulation were altered after intrathecal injection, at the level of the T1-T3 spinal cord, of either SP antagonist [D-Pro(2), D-Phe(7), D-Trp(9)]-SP, SP antagonist CP 96,345, or SP antiserum. Although MAP and heart rate responses to PPr stimulation were attenuated by intrathecal SP antagonists or antiserum, MAP responses to rVLM stimulation were augmented. Previous studies have revealed differences in transmitters associated with these two areas, even though the general response of both areas is sympathoexcitatory. The present study implies that the identical substance may increase or decrease the MAP response depending on the pathway activated.
No takes yet. Share an insight, caveat, or question.
Swiatkowski et al. (1999) studied this question. Intrathecal injection of substance P antagonists or antiserum was evaluated on Mean arterial blood pressure (MAP) and heart rate responses to PPr and rVLM stimulation. Intrathecal substance P antagonists or antiserum attenuated MAP and heart rate responses to PPr stimulation but augmented MAP responses to rVLM stimulation in anesthetized cats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: